EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin

Jiyuan Ma, Jianwei Zhao, Lan Gao, Neil Smith, Kim Ingalls, Lee Golden, Ronald Kong

Drug Metabolism and Disposition · 2026-11 · 100430

DOI: 10.1016/j.dmd.2026.100430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-11. Verfasst von Jiyuan Ma und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PTC Therapeutics Inc.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepiapterin is a precursor of tetrahydrobiopterin (BH 4 ), an essential cofactor for enzymes that metabolize phenylalanine and other aromatic amino acids to produce neurotransmitters. Synthetic sepiapterin, marketed as Sephience, is recently approved as a once-daily treatment of children and adults living with phenylketonuria (PKU) in Europe, United States, and other regions. Exogenously delivered synthetic sepiapterin is orally bioavailable and the conversion of sepiapterin to BH 4 is rapid and extensive in all animal species studied. Following oral dose administration, the metabolism and disposition of sepiapterin is species dependent. Volatile metabolite(s) formation in intestinal tract and the incorporation of sepiapterin and/or its metabolites into biosynthesis of other biological molecules may contribute to low mass balance recovery of dosed radioactivity in monkeys and humans, whereas there is limited impact in rats, reflected by high mass balance recovery of dosed radioactivity and high extraction efficiency of plasma radioactivity. The metabolism of exogenously delivered sepiapterin was extensive in rats, monkeys and humans following oral dose. The metabolite profiles were generally comparable across species evaluated, with major metabolic pathways involving hydrogenation/reduction, dehydrogenation, oxidation, methylation, and side chain cleavage, alone or in combination thereof.

Förderung

  • PTC Therapeutics Inc

Zitieren

APA

Ma, J., Zhao, J., Gao, L., Smith, N., Ingalls, K., Golden, L., & Kong, R. (2026). Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin. Drug Metabolism and Disposition, 100430. https://doi.org/10.1016/j.dmd.2026.100430

Vancouver

Ma J, Zhao J, Gao L, Smith N, Ingalls K, Golden L, et al. Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin. Drug Metabolism and Disposition. 2026:100430. doi:10.1016/j.dmd.2026.100430

BibTeX
@article{Ma2026,
  author = {Ma, Jiyuan and Zhao, Jianwei and Gao, Lan and Smith, Neil and Ingalls, Kim and Golden, Lee and Kong, Ronald},
  title = {Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  pages = {100430},
  doi = {10.1016/j.dmd.2026.100430}
}
Kostenlos starten →